| Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
| GHRHR |
growth hormone releasing hormone receptor |
7p14 |
rSNP target |
0
|
| OPRL1 |
opiate receptor-like 1 |
20q13.33 |
Literature-origin, Mapped by Literature SNP |
0
|
| HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
13q14-q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
4(2/2/0)
|
| DRD4 |
dopamine receptor D4 |
11p15.5 |
Literature-origin, Mapped by Literature SNP |
7(2/5/0)
|
| OXTR |
oxytocin receptor |
3p25 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
| GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
| GRID1 |
glutamate receptor, ionotropic, delta 1 |
10q22 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
| GABRA2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
4p12 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
3(1/2/0)
|
| ADCYAP1R1 |
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
7p14.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
19(8/11/0)
|
| CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(0/2/0)
|
| GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
Literature-origin |
1(0/0/1)
|
| NR3C1 |
nuclear receptor subfamily 3 group C member 1 |
5q31-q32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
6(2/4/0)
|
| CRHR1 |
corticotropin releasing hormone receptor 1 |
17q21.31 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
12(6/6/0)
|
| CRHR2 |
corticotropin releasing hormone receptor 2 |
7p14.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(2/0/0)
|
| ADRB2 |
adrenoceptor beta 2 |
5q31-q32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
| VIPR1 |
vasoactive intestinal peptide receptor 1 |
3p22 |
rSNP target |
0
|
| GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
9q22.1-q22.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
| GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
| DRD2 |
dopamine receptor D2 |
11q23.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
18(11/7/0)
|
| GABRG3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
15q12 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
| DRD3 |
dopamine receptor D3 |
3q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(1/1/0)
|
| HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
5q12.3 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
Basic Info
